Evidence map›Paper›PMID 41936073›Full record

ArticleBioinformatics (Oxford, England)2026

HybridGNN: a graph neural network approach for human miRNA-disease association prediction.

Basharat Ahmad, Muhammad Hammad Musaddiq, Sebu Aboma Temesgen, Grace-Mercure Bakanina Kissanga, Huma Fida, Hao Lin, Ye-Chen Qi

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Basharat AhmadSchool of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 611731, China.
Muhammad Hammad MusaddiqSchool of Information and Communication Engineering, University of Electronic Science and Technology of China, Chengdu 611731, China.
Sebu Aboma TemesgenSchool of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 611731, China.
Grace-Mercure Bakanina KissangaSchool of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 611731, China.
Huma FidaSchool of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 611731, China.
Hao LinSchool of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 611731, China.ORCID 0000-0001-6265-2862
Ye-Chen QiSchool of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 611731, China.ORCID 0000-0003-3615-3415

Funding

Fundamental Research Funds for the Central Universities ZYGX2024Z011
6 · The paper itself

Abstract

motivationMicroRNAs (miRNAs) are small non-coding RNAs, typically 18-24 nucleotides in length, that play a pivotal role in RNA silencing and the post-transcriptional regulation of gene expression by targeting messenger RNAs (mRNAs). Dysregulation of these miRNAs has consistently been implicated in the onset and progression of a variety of complex human diseases.

resultsIn this study, we propose a novel HybridGNN model that integrates a Graph Convolutional Network (GCN), a Graph Attention Network (GAT), and Matrix Decomposition with Matrix Factorization (MDMF) to predict potential miRNA-disease associations (MDAs). We incorporate five types of similarity in which three are derived from miRNAs and two are derived from diseases, to comprehensively explore and optimize multi-source feature information. The complementary interactions among these modules also help to mitigate the oversmoothing problem. The model utilizes neighboring nodes in a heterogeneous network to generate node embeddings via a message-passing mechanism. To improve computational efficiency, we employ a mini-batch gradient descent approach that partitions the graph into smaller sub-graphs, thereby enhancing the model's accuracy, speed, and scalability. As a result of these advanced techniques, HybridGNN achieved an area under the receiver operating characteristic curve (AUC-ROC) of 0.9715 using a dot-product classifier, outperforming several existing methods and underscoring its potential as a robust and accurate tool for predicting MDAs. AVAILABILITY: Code and data are freely available at https://github.com/mbasharatahmad/HybridGNN-miRNA-disease/.

Indexed as

Computational BiologyGraph Neural NetworksMicroRNAsAlgorithmsHumansMicroRNAs

Identifiers

PMID41936073
PMCPMC13171610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.